Profile data is unavailable for this security.
About the company
Centene Corporation is a healthcare company. The Company provides services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. It provides a range of managed healthcare products and services, primarily through Medicaid, Medicare, and commercial products. Its segments include Medicaid, Medicare, Commercial and Other. It offers Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program. It also contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Medicaid program provides health insurance to low-income families and individuals with disabilities. Medicare is a federal health insurance program for people ages 65 and over, which also covers people under 65 with certain disabilities and people with end-stage renal diseases.
- Revenue in USD (TTM)154.00bn
- Net income in USD2.70bn
- Incorporated2001
- Employees67.70k
- LocationCentene Corp7700 Forsyth BlvdST. LOUIS 63105-1807United StatesUSA
- Phone+1 (314) 725-4477
- Fax+1 (302) 655-5049
- Websitehttps://www.centene.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemed Corp | 2.26bn | 272.51m | 9.70bn | 15.09k | 35.82 | 8.71 | 29.11 | 4.29 | 17.92 | 17.92 | 148.99 | 73.69 | 1.46 | 131.59 | 14.11 | 150,090.60 | 17.52 | 19.53 | 21.79 | 24.64 | 35.28 | 34.60 | 12.03 | 12.60 | 1.57 | -- | 0.014 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
Tenet Healthcare Corp | 20.55bn | 611.00m | 10.51bn | 78.14k | 18.02 | 6.53 | 4.82 | 0.5115 | 5.83 | 5.83 | 196.00 | 16.09 | 0.7409 | 8.80 | 6.58 | 262,950.40 | 4.73 | 3.61 | 6.75 | 5.09 | 82.53 | 82.97 | 6.38 | 4.95 | 1.42 | 4.15 | 0.7315 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
Davita Inc | 12.14bn | 691.54m | 12.11bn | 70.00k | 18.63 | 11.61 | 7.11 | 0.9973 | 7.41 | 7.41 | 130.29 | 11.89 | 0.7179 | 65.97 | 5.89 | 173,430.70 | 5.66 | 5.62 | 7.55 | 7.45 | 31.47 | 30.70 | 7.88 | 8.33 | 1.13 | 4.77 | 0.7536 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
Universal Health Services, Inc. | 14.28bn | 717.49m | 12.27bn | 73.35k | 17.80 | 1.99 | 9.53 | 0.8588 | 10.25 | 10.25 | 203.66 | 91.53 | 1.04 | -- | 6.71 | 194,710.00 | 5.24 | 6.44 | 6.14 | 7.63 | -- | -- | 5.04 | 6.55 | 1.29 | 5.69 | 0.442 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
Quest Diagnostics Inc | 9.25bn | 850.00m | 14.74bn | 40.00k | 17.78 | 2.34 | 11.16 | 1.59 | 7.49 | 7.49 | 81.52 | 56.82 | 0.6889 | 32.39 | 7.69 | 231,300.00 | 6.57 | 9.28 | 7.58 | 10.81 | 33.14 | 36.64 | 9.53 | 12.97 | 1.20 | 8.47 | 0.4234 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
Laboratory Corporation of Amerc Holdings | 12.16bn | 379.20m | 18.37bn | 67.00k | 51.86 | 2.33 | 19.18 | 1.51 | 4.21 | 4.65 | 139.11 | 93.86 | 0.6595 | 18.61 | 4.75 | 181,516.40 | 2.06 | 6.27 | 2.49 | 7.37 | 27.67 | 32.33 | 3.13 | 9.51 | 1.02 | 5.89 | 0.3944 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
Molina Healthcare Inc | 34.07bn | 1.09bn | 24.07bn | 18.00k | 21.85 | 5.65 | 19.07 | 0.7064 | 18.81 | 18.81 | 587.20 | 72.67 | 2.50 | -- | 12.61 | 1,892,889.00 | 8.02 | 7.62 | 17.91 | 16.80 | 15.86 | 15.99 | 3.20 | 3.04 | -- | 14.81 | 0.3614 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
Humana Inc | 106.37bn | 2.49bn | 41.80bn | 67.60k | 17.49 | 2.61 | 12.07 | 0.3929 | 19.83 | 19.83 | 855.93 | 133.05 | 2.36 | -- | -- | 1,573,580.00 | 5.65 | 7.57 | -- | -- | -- | -- | 2.39 | 3.35 | -- | 9.25 | 0.4167 | 12.54 | 14.54 | 13.33 | -11.30 | 7.65 | 10.41 | 13.25 |
Centene Corp | 154.00bn | 2.70bn | 41.98bn | 67.70k | 15.97 | 1.62 | 10.46 | 0.2726 | 4.91 | 4.91 | 282.18 | 48.35 | 1.91 | -- | 10.69 | 2,274,727.00 | 3.34 | 2.58 | 5.62 | 3.99 | 11.24 | 11.59 | 1.75 | 1.37 | -- | 4.70 | 0.4072 | 0.00 | 6.54 | 20.70 | 124.79 | 24.59 | 3.43 | -- |
HCA Healthcare Inc | 64.97bn | 5.24bn | 88.21bn | 220.00k | 17.57 | -- | 9.62 | 1.36 | 18.98 | 18.98 | 235.03 | -6.68 | 1.20 | 4.84 | 6.89 | 295,309.10 | 11.21 | 11.99 | 15.12 | 15.75 | 84.76 | 84.10 | 9.38 | 10.17 | 1.02 | 5.02 | 0.9739 | 10.54 | 7.86 | 6.84 | -7.11 | 10.13 | 5.83 | 11.38 |
Cigna Group | 195.27bn | 5.16bn | 106.18bn | 72.50k | 20.89 | 2.30 | 12.63 | 0.5438 | 17.39 | 17.39 | 657.71 | 158.03 | 1.32 | 32.64 | 11.18 | 2,693,310.00 | 3.62 | 4.09 | 5.20 | 5.55 | 12.89 | 13.98 | 2.75 | 3.61 | 0.6508 | 5.93 | 0.4002 | 13.69 | 8.17 | 32.15 | -22.97 | 14.42 | 24.40 | 161.81 |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Dec 2023 | 58.88m | 11.01% |
Capital Research & Management Co. (World Investors)as of 31 Dec 2023 | 29.15m | 5.45% |
Fidelity Management & Research Co. LLCas of 31 Dec 2023 | 26.08m | 4.88% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 24.19m | 4.52% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 23.14m | 4.33% |
Wellington Management Co. LLPas of 31 Dec 2023 | 20.20m | 3.78% |
Norges Bank Investment Managementas of 31 Dec 2023 | 17.86m | 3.34% |
Politan Capital Management LPas of 31 Dec 2023 | 12.14m | 2.27% |
Swedbank Robur Fonder ABas of 29 Feb 2024 | 11.71m | 2.19% |
Harris Associates LPas of 31 Dec 2023 | 10.86m | 2.03% |